These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 3530620)

  • 61. Doxofylline: a "novofylline".
    Page CP
    Pulm Pharmacol Ther; 2010 Aug; 23(4):231-4. PubMed ID: 20380886
    [TBL] [Abstract][Full Text] [Related]  

  • 62. COPD. Assessing functional status.
    Daly WJ
    Hosp Pract (Off Ed); 1985 Mar; 20(3A):73-7, 82-5, 89-93. PubMed ID: 3932414
    [No Abstract]   [Full Text] [Related]  

  • 63. [Theophylline therapy in obstructive respiratory diseases. 1. Bioavailability and pharmacokinetics of various theophylline preparations (author's transl)].
    Wemhöner S; Oellerich M; Sybrecht G
    Prax Klin Pneumol; 1981 Jan; 35(1):36-41. PubMed ID: 7208408
    [No Abstract]   [Full Text] [Related]  

  • 64. [Effect of inhalation of an atropine derivative (SCH 1000) on airway resistance to flow and on specific conductance in patients with chronic obstructive bronchopneumopathy].
    Anastasatu C; Duţu S
    Ftiziologia; 1974 May; 23(3):305-10. PubMed ID: 4842470
    [No Abstract]   [Full Text] [Related]  

  • 65. Adenosine is worth trying in patients with paroxysmal supraventricular tachycardia on chronic theophylline medication.
    Giagounidis AA; Schäfer S; Klein RM; Aul C; Strauer BE
    Eur J Med Res; 1998 Aug; 3(8):380-2. PubMed ID: 9707519
    [TBL] [Abstract][Full Text] [Related]  

  • 66. [Therapy of chronic obstructive respiratory syndrome with the new theophylline preparation Afonilum retard].
    Dettmer HH
    Fortschr Med; 1981 Jul; 99(25):1007-11. PubMed ID: 7262783
    [No Abstract]   [Full Text] [Related]  

  • 67. Obstructive lung disease and bronchodilator therapy.
    Chapman TT
    Ther Umsch; 1971 Nov; 28(11):720-3. PubMed ID: 5151792
    [No Abstract]   [Full Text] [Related]  

  • 68. [Guacetisal in the treatment of acute and chronic bronchopneumopathy].
    Carpinteri F; Carosi M
    Minerva Med; 1981 Feb; 72(7):347-53. PubMed ID: 7017484
    [TBL] [Abstract][Full Text] [Related]  

  • 69. [New developments in the field of bronchospasmolytics].
    Nolte D
    Clin Ter; 1980 Jan; 92(1):3-13. PubMed ID: 7449306
    [No Abstract]   [Full Text] [Related]  

  • 70. Maintenance of bronchodilation in chronic reversible airways obstruction. Comparison between choline theophyllinate and salbutamol.
    Tanser AR
    Practitioner; 1982 Mar; 226(1365):569-71. PubMed ID: 7045848
    [No Abstract]   [Full Text] [Related]  

  • 71. [Is routine monitoring of theophylline blood levels really effective?].
    Atsmon J; Priel IE; Dolev E
    Harefuah; 1995 Nov; 129(9):304-8, 368. PubMed ID: 8549976
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Reassessing the therapeutic range for theophylline on laboratory report forms: another viewpoint.
    Jenne JW
    Pharmacotherapy; 1993; 13(6):595-7. PubMed ID: 8302683
    [No Abstract]   [Full Text] [Related]  

  • 73. [Drug treatment of chronic obstructive pulmonary disease].
    van Herwaarden CL; Dekhuijzen PN; van Schayck CP; van Weel C; Molema J
    Ned Tijdschr Geneeskd; 1996 Apr; 140(14):761-5. PubMed ID: 8668261
    [No Abstract]   [Full Text] [Related]  

  • 74. [Respiratory medicine in the aged. Therapeutic problemsd].
    Leonardi R; Cossi S; De Martinis M; Ghisla MK; Tomasi MF; Grassi V
    Recenti Prog Med; 1997 Dec; 88(12):566-73. PubMed ID: 9522597
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Objective assessment of a bronchodilator drug combination in asthmatic outpatients.
    Mattila MJ; Alanko K
    Curr Ther Res Clin Exp; 1973 Jun; 15(6):273-84. PubMed ID: 4197251
    [No Abstract]   [Full Text] [Related]  

  • 76. Effects of theophylline on respiratory drive in patients with chronic obstructive pulmonary disease.
    Ashutosh K; Sedat M; Fragale-Jackson J
    J Clin Pharmacol; 1997 Dec; 37(12):1100-7. PubMed ID: 9506004
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Newer aspects of therapy for obstructive pulmonary disease.
    Anderson DE
    Rocky Mt Med J; 1979; 76(2):72-8. PubMed ID: 373064
    [No Abstract]   [Full Text] [Related]  

  • 78. Proceedings of the Theophylline Forum. Stockholm, 25 June 1994.
    Clin Exp Allergy; 1996 Mar; 26 Suppl 2():1-59. PubMed ID: 8963869
    [No Abstract]   [Full Text] [Related]  

  • 79. Poor bronchodilator effect of oral etamiphylline in asthmatic children.
    Vazquez C; Labayru T; Rodriguez-Soriano J
    Lancet; 1984 Apr; 1(8382):914. PubMed ID: 6143224
    [No Abstract]   [Full Text] [Related]  

  • 80. The effects of theophylline on airway inflammation.
    Pauwels R
    Chest; 1987 Jul; 92(1 Suppl):32S-37S. PubMed ID: 3297525
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.